Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-09-09 Purchase | 2019-09-11 1:32 pm | PROGENICS PHARMACEUTICALS INC | PGNX | Velan Capital L.P. Altiva Management Inc. VENKATARAMAN BALAJI See Explanation of Responses 10% Owner | 72,023 | $4.9947 | $359,733 | 8,011,733 (Direct) | View |
| 2019-09-05 Purchase | 2019-09-09 6:14 pm | PROGENICS PHARMACEUTICALS INC | PGNX | LTE Partners LLC Melkonian Capital Management LLC LTE Management LLC Melkonian Ryan See Explanation of Responses 10% Owner | 65,000 | $4.7261 | $307,193 | 1,950,000 (Direct) | View |
| 2019-09-03 Purchase | 2019-09-05 4:37 pm | PROGENICS PHARMACEUTICALS INC | PGNX | Velan Capital L.P. Altiva Management Inc. VENKATARAMAN BALAJI See Explanation of Responses 10% Owner | 521,038 | $4.4477 | $2,317,446 | 7,939,710 (Direct) | View |
| 2019-08-23 Purchase | 2019-08-27 3:45 pm | PROGENICS PHARMACEUTICALS INC | PGNX | Velan Capital L.P. Altiva Management Inc. VENKATARAMAN BALAJI See Explanation of Responses 10% Owner | 204,056 | $4.3057 | $878,601 | 7,418,672 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-06-19 Disposition | 2020-06-23 4:49 pm | N/A 2029-02-01 | PROGENICS PHARMACEUTICALS INC | PGNX | Das Asha Chief Medical Officer | 207,214 | $0 | 0 (Direct) | View |
| 2020-06-19 Disposition | 2020-06-23 4:49 pm | N/A 2028-02-29 | PROGENICS PHARMACEUTICALS INC | PGNX | Osorio Benedict COO | 294,166 | $0 | 0 (Direct) | View |
| 2020-06-19 Disposition | 2020-06-23 4:49 pm | N/A 2026-10-02 | PROGENICS PHARMACEUTICALS INC | PGNX | Tenbarge Bryce SVP, Commercial | 389,864 | $0 | 0 (Direct) | View |
| 2020-06-19 Disposition | 2020-06-23 4:48 pm | N/A 2020-06-30 | PROGENICS PHARMACEUTICALS INC | PGNX | Wong Vivien EVP, Development | 809,760 | $0 | 0 (Direct) | View |
| 2020-06-19 Disposition | 2020-06-23 4:48 pm | N/A 2029-12-13 | PROGENICS PHARMACEUTICALS INC | PGNX | Mims David W. Interim CEO and Interim CFO | 56,393 | $0 | 0 (Direct) | View |
| 2020-06-19 Disposition | 2020-06-23 4:48 pm | N/A 2029-12-13 | PROGENICS PHARMACEUTICALS INC | PGNX | Ber Gerard Director | 106,393 | $0 | 0 (Direct) | View |
| 2020-06-19 Disposition | 2020-06-23 4:47 pm | N/A 2026-06-07 | PROGENICS PHARMACEUTICALS INC | PGNX | Campbell Bradley L Director | 110,000 | $0 | 0 (Direct) | View |
| 2020-06-19 Disposition | 2020-06-23 4:47 pm | N/A 2029-12-13 | PROGENICS PHARMACEUTICALS INC | PGNX | Ende Eric J Director | 56,393 | $0 | 0 (Direct) | View |
| 2020-06-19 Disposition | 2020-06-23 4:47 pm | N/A 2024-01-28 | PROGENICS PHARMACEUTICALS INC | PGNX | Ferrante Karen Jean Director | 170,000 | $0 | 0 (Direct) | View |
| 2020-06-19 Disposition | 2020-06-23 4:46 pm | N/A 2029-12-13 | PROGENICS PHARMACEUTICALS INC | PGNX | MacDougall Ann L. Director | 76,065 | $0 | 0 (Direct) | View |
| 2020-06-19 Disposition | 2020-06-23 4:46 pm | N/A 2029-12-13 | PROGENICS PHARMACEUTICALS INC | PGNX | Maeusli Heinz Christoph Director | 56,393 | $0 | 0 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:15 pm | N/A 2030-03-02 | PROGENICS PHARMACEUTICALS INC | PGNX | Das Asha Chief Medical Officer | 82,214 | $0 | 82,214 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:15 pm | N/A 2030-03-02 | PROGENICS PHARMACEUTICALS INC | PGNX | Osorio Benedict COO | 82,214 | $0 | 82,214 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:15 pm | N/A 2030-03-02 | PROGENICS PHARMACEUTICALS INC | PGNX | Wong Vivien EVP, Development | 82,214 | $0 | 82,214 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:15 pm | N/A 2030-03-02 | PROGENICS PHARMACEUTICALS INC | PGNX | Tenbarge Bryce SVP, Commercial | 82,214 | $0 | 82,214 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:15 pm | N/A 2030-03-02 | PROGENICS PHARMACEUTICALS INC | PGNX | Fabbio Patrick CFO | 82,214 | $0 | 82,214 (Direct) | View |
| 2019-12-13 Option Award | 2019-12-17 3:16 pm | 2019-12-13 2029-12-13 | PROGENICS PHARMACEUTICALS INC | PGNX | Maeusli Heinz Christoph Director | 16,393 | $0 | 16,393 (Direct) | View |
| 2019-12-13 Option Award | 2019-12-17 3:16 pm | N/A 2029-12-13 | PROGENICS PHARMACEUTICALS INC | PGNX | Maeusli Heinz Christoph Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2019-12-13 Option Award | 2019-12-17 3:16 pm | 2019-12-13 2029-12-13 | PROGENICS PHARMACEUTICALS INC | PGNX | Mims David W. Director | 16,393 | $0 | 16,393 (Direct) | View |
| 2019-12-13 Option Award | 2019-12-17 3:15 pm | N/A 2029-12-13 | PROGENICS PHARMACEUTICALS INC | PGNX | Mims David W. Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2019-12-13 Option Award | 2019-12-17 3:15 pm | 2019-12-13 2029-12-13 | PROGENICS PHARMACEUTICALS INC | PGNX | MacDougall Ann L. Director | 36,065 | $0 | 36,065 (Direct) | View |
| 2019-12-13 Option Award | 2019-12-17 3:15 pm | N/A 2029-12-13 | PROGENICS PHARMACEUTICALS INC | PGNX | MacDougall Ann L. Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2019-12-13 Option Award | 2019-12-17 3:14 pm | 2019-12-13 2029-12-13 | PROGENICS PHARMACEUTICALS INC | PGNX | Ende Eric J Director | 16,393 | $0 | 16,393 (Direct) | View |
| 2019-12-13 Option Award | 2019-12-17 3:14 pm | N/A 2029-12-13 | PROGENICS PHARMACEUTICALS INC | PGNX | Ende Eric J Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2019-12-13 Option Award | 2019-12-17 3:14 pm | 2019-12-13 2029-12-13 | PROGENICS PHARMACEUTICALS INC | PGNX | Ber Gerard Director | 16,393 | $0 | 16,393 (Direct) | View |
| 2019-12-13 Option Award | 2019-12-17 3:14 pm | N/A 2029-12-13 | PROGENICS PHARMACEUTICALS INC | PGNX | Ber Gerard Director | 40,000 | $0 | 40,000 (Direct) | View |
Ownership | 2019-09-27 5:23 pm | N/A N/A | PROGENICS PHARMACEUTICALS INC | PGNX | MacDougall Ann L. See Explanation of Responses 10% Owner | 0 | $0 | 0 (Direct) | View |
Ownership | 2019-09-27 5:21 pm | N/A N/A | PROGENICS PHARMACEUTICALS INC | PGNX | Mims David W. See Explanation of Responses 10% Owner | 0 | $0 | 0 (Direct) | View |
Ownership | 2019-09-27 5:18 pm | N/A N/A | PROGENICS PHARMACEUTICALS INC | PGNX | Maeusli Heinz Christoph See Explanation of Responses 10% Owner | 0 | $0 | 0 (Direct) | View |
Ownership | 2019-09-27 5:16 pm | N/A N/A | PROGENICS PHARMACEUTICALS INC | PGNX | Ende Eric J See Explanation of Responses 10% Owner | 0 | $0 | 0 (Direct) | View |
Ownership | 2019-09-27 5:13 pm | N/A N/A | PROGENICS PHARMACEUTICALS INC | PGNX | Ber Gerard See Explanation of Responses 10% Owner | 0 | $0 | 50,000 (Direct) | View |
Ownership | 2019-08-27 3:42 pm | N/A N/A | PROGENICS PHARMACEUTICALS INC | PGNX | Velan Capital L.P. Altiva Management Inc. VENKATARAMAN BALAJI See Explanation of Responses 10% Owner | 0 | $0 | 7,214,616 (Direct) | View |
Ownership | 2019-08-27 3:39 pm | N/A N/A | PROGENICS PHARMACEUTICALS INC | PGNX | Nohria Virinder See Explanation of Responses 10% Owner | 0 | $0 | 110,000 (Direct) | View |
Ownership | 2019-08-27 3:37 pm | N/A N/A | PROGENICS PHARMACEUTICALS INC | PGNX | LTE Partners LLC Melkonian Capital Management LLC LTE Management LLC Melkonian Ryan See Explanation of Responses 10% Owner | 0 | $0 | 1,885,000 (Direct) | View |
Ownership | 2019-08-27 3:29 pm | N/A N/A | PROGENICS PHARMACEUTICALS INC | PGNX | Sarpangal Deepak See Explanation of Responses 10% Owner | 0 | $0 | 0 (Direct) | View |
Ownership | 2019-08-27 3:25 pm | N/A N/A | PROGENICS PHARMACEUTICALS INC | PGNX | Cooke Terence See Explanation of Responses 10% Owner | 0 | $0 | 40,000 (Direct) | View |